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Bariatric surgery, also known as metabolic surgery, is an effective treatment for morbid
obesity, which also offers pronounced metabolic effects including the resolution of type 2
diabetes and a decrease in cardiovascular disease and long-term cancer risk. However,
the mechanisms of surgical weight loss and the long-term consequences of bariatric
surgery remain unclear. Bariatric surgery has been demonstrated to alter the composi-
tion of both the microbiome and the metabolic phenotype. We observed a marked shift
toward Gammaproteobacteria, particularly Enterobacter hormaechei, following Roux-en-Y
gastric bypass (RYGB) surgery in a rat model compared with sham-operated controls. Fecal
water from RYGB surgery rats was highly cytotoxic to rodent cells (mouse lymphoma cell
line). In contrast, fecal water from sham-operated animals showed no/very low cytotoxi-
city. This shift in the gross structure of the microbiome correlated with greatly increased
cytotoxicity. Urinary phenylacetylglycine and indoxyl sulfate and fecal gamma-aminobutyric
acid, putrescine, tyramine, and uracil were found to be inversely correlated with cell sur-
vival rate. This profound co-dependent response of mammalian and microbial metabolism
to RYGB surgery and the impact on the cytotoxicity of the gut luminal environment sug-
gests that RYGB exerts local and global metabolic effects which may have an inﬂuence on
long-term cancer risk and cytotoxic load.
Keywords: obesity, bariatric surgery, Roux-en-Y gastric bypass, microbial profile, 16S rRNA, metabolic profile,
cytotoxicity, gammaproteobacteria
INTRODUCTION
Obesity is worldwide epidemic with 1.5 billion adults
(age> 20 years) and 43 million children under the age of 5 over-
weight, of which approximately 500 million are clinically obese
(BMI> 30; WHO, 2006). Obesity and its comorbidities impose a
substantial healthcare burden which are associated with mount-
ing international healthcare costs (Eckel et al., 2005; Ashraﬁan
et al., 2011c).Although several treatment strategies such as lifestyle
modiﬁcation (Wing and Phelan, 2005) and medications have
been used to combat obesity, their long-term efﬁcacy has yet
to be demonstrated. Bariatric surgery, also called weight loss or
metabolic surgery, was introduced 50 years ago to provide dras-
tic weight loss in morbidly obese patients (Kremen et al., 1954;
Ashraﬁan et al., 2010) and is now increasingly used to treat patients
with lower adiposity, or occasionally purely for metabolic beneﬁt
(Ashraﬁan et al., 2011b). Currently the three most common types
of bariatric surgery are the Roux-en-Y gastric bypass (RYGB),
Adjustable Gastric Band and the Sleeve Gastrectomy. Of these, the
RYGB is considered to be the “gold standard” procedure due to its
established efﬁcacy,metabolic beneﬁts, and safety fromside effects.
Typically the RYGB operation is performed laparoscopically and
consists of the creation of a small stomach pouch (30–50ml)
that is divided from a larger gastric remnant. The small bowel
(jejunum) is bypassed approximately 50 cm below the stomach
outlet (“biliopancreatic limb”) in a Y-structured conﬁguration.
This anatomical rearrangement allows food from the outlet of the
small stomach pouch to enter directly into the small intestine (“ali-
mentary limb”). Both biliopancreatic and alimentary limbs are
attached to a “common channel” to complete the Y-conﬁguration
(Ashraﬁan et al., 2010). This surgical procedure induces a series
of physical and metabolic sequelae characterized as the BRAVE
effects: Bile ﬂow alteration; Reduction of gastric size; Anatomical
gut rearrangement and altered ﬂow of nutrients; Vagal manipula-
tion; and Enteric gut hormonemodulation (Ashraﬁan et al., 2010)
leading to effective weight loss and resolution of type 2 diabetes.
Modulation of the enteric gut microbiota has been reported
in both animal and human clinical studies post-RYGB surgery,
although whether these changes are etiopathogenic or conse-
quential is not yet clear. A direct effect on the microbiota post-
RYGB surgery (Zhang et al., 2009) where a dramatic increase
in the gammaproteobacteria population compared with control
and obese subjects was demonstrated in a clinical study. This
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ﬁnding was supported by similar observation in an experimen-
tal RYGB study in rats. Other studies have characterized the
indirect effects of RYGB in altered gut microbial metabolites or
microbial–mammalian co-metabolites in bioﬂuids. Serum sphin-
gosines, unsaturated fatty acids, and branched chain amino acids
altered signiﬁcantly in obese patients within 3months post-RYGB
(Mutch et al., 2009). This study also found a strong negative cor-
relation between serum nervonic acid concentrations and insulin
resistance (HOMA-IR). In a separate weight loss control study,
amino acids and branched chain amino acids were found to
decrease post-RYGB but not after dietary intervention, which sug-
gested the down-regulation of amino acids may contribute to
the glucose homeostasis and thus improve the metabolic status
(Laferrere et al., 2011). Using a rat RYGB model, we previously
characterized the correlation between the metabolic and metage-
nomic proﬁles following RYGB surgery (Li et al., 2011). Metabolic
effects of surgery included a reduction in levels of TCA cycle inter-
mediates, increased amine production (methylamine, trimethy-
lamine, and putrescine), and increased production of microbial-
derived metabolites such as propionate and 5-aminovalerate, or
microbial–host co-metabolites (e.g., hippurate, 4-cresyl sulfate,
4-cresyl glucuronide, 4-hydroxyphenylacetate, and phenylacetyl-
glycine). Thesemicrobial-relatedmetabolites were positively asso-
ciated with Gammaproteobacteria, particularly, with Enterobacter
hormaechei and negatively associated with Clostridia (Li et al.,
2011).
Epidemiological analyses suggest that reduced risks of cardio-
vascular disease and cancer (especially colonic) are long-term
beneﬁts of bariatric surgery, but the molecular mechanisms of
these associations are poorly understood (Ashraﬁan et al., 2011a).
As there is a general reduction in the incidence of cancer follow-
ing RYGB surgery in man (Adams et al., 2007; Sjostrom et al.,
2009) and there is a marked and long-term stable alteration in
fecal bacterial composition following surgerywehypothesized that
the protective effects of bariatric surgery could be mediated by
the altered bioavailability of microbial cytotoxins and genotoxins.
Fecal matter has been shown to be genotoxic (Lee et al., 2005), and
it is well-established that diet-related fecal cytotoxicity and geno-
toxicity are strongly correlated with colon cancer risk (de Kok
and van Maanen, 2000). Thus, it is possible that bariatric surgery
modiﬁes diet-associated exposure to cancer-inducing chemicals
and this might be expected to inﬂuence the diet-borne genotoxic
burden in the exposome. Hence, in order to determine the inﬂu-
ence of bariatric surgery on the cytotoxic and genotoxic burden
of fecal material, fecal water extracts obtained from RYGB and
sham-operated rats were analyzed using a well-established in vitro
mammalian cell mutation assay. Contrary to our initial hypothesis
we found dramatically increased cytotoxicity in the fecal water of
rats post-RYGB surgery,which prompts further questions as to the
suitability of the rat as a model for RYGB surgery.
MATERIALS AND METHODS
ANIMAL MODEL
The animal experiment was carried out under a license autho-
rized by the UK Home ofﬁce (PL 70-6669) and the experiment
details have been previously described in Li et al. (2011). Brieﬂy,
12 male Wistar rats (non-obese) were housed in individual cages
and kept under a 12/12-h light/dark cycle at a room temper-
ature of 21± 2˚C. All rats were administered intraperitoneally
with 1ml amoxicillin/ﬂucloxacillin solution (both at 12.5mg/ml)
pre-operation as standard prophylaxis against post-operative sep-
sis, both sham and RYGB rats received antibiotics to control
antibiotic-related variations including the modulation of gut
microbiota. This is consistent with common practice in human
clinical operations. A total of six rats were subject to RYGB surgery
RYGB whilst the others underwent a sham procedure and served
as the control group. Fecal and urine samples were collected for
24 h pre-operation and at 2, 4, 6 and 8weeks post operation.
CELL CULTURE
Mouse lymphoblastoid L5178Y cells were obtained from ATCC.
L5178Y cells were cultured in RPMI 1640 media supplemented
with 10%v/v heat inactivated horse serum, 2mM l-glutamine,
0.1%v/v F68 pluronic, 100 units/ml penicillin, and 100μg/ml
streptomycin (Clements, 2000).
FECAL WATER EXTRACTION
In order to ensure the reproducibility of the fecal extraction and
cell treatment, two separate experiments were performed. Firstly,
a fecal pellet from each of six sham and six RYGB-operated rats
at weeks 2 and 8 post operation were weighed (∼200mg) and
homogenized in distilled water by vigorously vortexing. A sepa-
rate pellet for each animal was pipetted into a 2-ml Eppendorf™,
containing 1.4ml of 0.2M sodium phosphate buffer (pH= 7.4)
containing 20% deuterium oxide (D2O) as a magnetic ﬁeld lock,
0.01% 3-(trimethylsilyl)-[2,2,3,3-2H4]propionic acid sodium salt
(TSP) as a spectral reference, and 3mM sodium azide to termi-
nate any bacterial activity, and homogenized. The sample was then
vortexed for 15 s, sonicated for 30min at 25˚C and centrifuged at
10392 g for 20min. A total of 700μl supernatant was taken into
a 1.5-ml Eppendorf™tube and centrifuged again under the same
conditions after which the supernatant (600μl) was taken into
an NMR tube. A third pellet was used to generate the 16S rRNA
data.
In the second experiment, four of the RYGB and four sham-
operated rats were randomly selected for further investigation.
Here, fecal pellets collected for each rat at each time point (pre-
surgery and 2, 4, 6, and 8weeks post surgery) were homogenized
and extracted to follow a more reﬁned time course. Samples were
then split into two aliquots for cytotoxicity/genotoxicity assays
and NMR analysis. All fecal extracts were then sterile ﬁltered
through a 0.2-μmmembrane and the same volume of fecal extract
equivalent to 20mg were used in cytotoxicity and genotoxicity
assays. Fecal pellet extracts for NMR analysis were mixed with
1.4ml of the aforementioned phosphate buffer. The mixture was
centrifuged at 1.0× 104 g for 20min and 600μl of supernatant
transferred into a 5-mm outer-diameter NMR tube (Beckonert
et al., 2010).
CYTOTOXICITY AND GENOTOXICITY ASSAY
Cytotoxicity and genotoxicity evaluation was performed as
described by Clements according to OECD guidelines (OECD,
1997; Clements, 2000). In brief, four million exponentially grow-
ing L5178Y cells were treated with sham or RYGB-operated fecal
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water extract for 24 h at 37˚C, 5% CO2. The ﬁnal treatment
concentration was 1mg fecal material per 1ml cell suspension
media. As a negative control, fecal water extract was replaced with
water. Ethyl methanesulfonate (EMS, 20μg/ml) and/or etopo-
side (73.5 ng/ml) were used as positive controls, unless otherwise
stated. Following treatment, L5178Y cells were washed, counted,
and the concentration of cells adjusted to 1.5× 105/ml to main-
tain exponential growth. Treated L5178Y cells were counted and
subcultured daily for a further 2 days to determine the relative
suspension growth (RSG; a measure of cell death and prolifer-
ative ability following treatment relative to the negative control
(Clements, 2000). On the third day, L5178Y cells were plated at
1.6 cells per well in 96 well plates to determine the cloning efﬁ-
ciency and 2,000 cells per well in triﬂuorothymidine (4μg/ml)
to determine the Thymidine kinase (tk) mutant frequency. Plates
were incubated for 14 days at 37˚C, 5%CO2 and then colonies were
scored.
NMR-BASED METABOLIC PROFILING OF FECAL WATER AND URINE
For each fecal pellet extract and urine sample 1-Dimensional pro-
ton NMR spectra of urine and fecal extracts were acquired using
a Bruker 600MHz spectrometer (Bruker, Rheinstetten, Germany)
with a standard NMR pulse sequence (recycle delay-90-t 1(3μs)-
90-tm(100ms)-90-acquisition) at 27˚C. Water suppression was
achievedusing selective irradiation during a recycle delay of 2 s and
tm, and a 90˚ pulse was 10μs (Beckonert et al., 2010). A total num-
ber of 128 scans were accumulated into 64 k data points for each
urine spectrum with a width of 20 ppm, whereas for fecal water
extracts, 512 scans were acquired due to the low concentration of
the samples.
MICOBIAL PROFILING VIA PYROSEQUENCING
The composition on the gutmicrobiota was determined by under-
taking a survey of the 16S rRNA genes in each animal. A modiﬁed
protocol based on the Qiagen Stool Kit (Qiagen, Crawley, UK)
with an additional bead beating step to homogenize and lyse bac-
teria in the samples (0.1 g 0.1mm sterile glass beads, 3× 4500 rpm
for 30 s with 5min on ice in between cycles) was used to extract
DNA from 250mg fecal pellets (Cole et al., 2009; Schloss et al.,
2009). The extracted DNA was quantiﬁed using the Invitrogen
Qubit platform and diluted to a working concentration of 10 ng
μl−1. PCR was used to amplify the V1–V3 regions of the 16S
rRNA gene from each DNA sample using the primers as published
in (Li et al., 2011). PCR mixtures (25μl) contained 1×Buffer
(20mM Tris pH 8.4, 50mM KCl), 1.5mM MgCl2, 200μM of
each dNTP, 1.25U of Taq polymerase (NEB, UK), 5 pmol of each
primer, and 10 ng of DNA. PCR was performed in triplicate on
all DNA extracts using a MJ Research PTC-200P Thermal Cycler
(MJ Research, USA). The PCR conditions were: 95˚C for 5min
initial denaturation, followed by 25 cycles of ampliﬁcation at 95˚C
denaturation for 30 s, annealing at 55˚C for 40 s, and extension of
72˚C for 1min, with a ﬁnal extension of 72˚C for 5min. Pooled
PCR products for each sample were puriﬁed using a Qiagen PCR
puriﬁcation kit, quantiﬁed and equimolar amounts pooled prior
to runningon a 1/4 of a PTP (Pico titer plate) using titaniumchem-
istry (AGOWA, Berlin, Germany). The sequences were binned
by sample source and any reads that were less than 250 bp were
removed. The ﬁltered sequences were classiﬁed using the RDP
classiﬁer and the relative proportions of phyla and families deter-
mined. Community analysis of the data was undertaken using
MOTHUR.
STATISTICAL CORRELATION ANALYSIS
1HNMRspectrawerephased,calibrated toTSP δ0.0,andbaseline-
corrected using an in house developed MATLAB script. The
pre-processed NMR spectra were then imported into MATLAB
(R2010b) platform with a resolution of 0.0005 ppm and water
peak (δ 4.7–4.9) and noise containing regions (δ 0–0.3, 9.4–10.0)
were removed to reduce the number of data points. The remaining
spectral data were normalized using probabilistic quotient nor-
malization method and then performed multivariate statistical
data analysis (Trygg et al., 2007) including principal component
analysis (PCA) and projection on latent structures (PLS) regres-
sion analysis. Statistical analysis used to calculate signiﬁcance in
cytotoxicity and genotoxicity assays was one way ANOVA with
Dunnett’s post hoc test compared to the negative control Correla-
tion of the cytotoxicity values with the 16S rRNA proﬁles was also
carried out.
RESULTS
CYTOTOXICITY AND GENOTOXICITY OF FECAL EXTRACTS
Fecal samples froma total of 12 rats atweeks 2 and 8post operation
were used for cytotoxicity, genotoxicity, and microbial composi-
tion evaluation. Cytotoxicity is reported as the RSG of the cells
following treatment; a measure of cell cycle arrest, cell death, and
clonogenicity. Unexpectedly, all RYGB samples exhibited strong
cytotoxic responses compared with sham samples (p< 0.001,
Figure 1A). No signiﬁcant difference in toxicity was observed
between the 2 and 8-week time points within the same group.
However, the mean RSG of RYGB-operated rats was markedly
lower than the sham-operated controls (p< 0.001; Figure 1A).
Fecal water samples were also examined for genotoxicity using the
TK locus in the regulatory acceptable Mouse Lymphoma L5178Y
mutation assay. Genotoxicity above the spontaneous background
rate (85× 10−6) was not observed with fecal water extracts from
RYGB or sham-operated rats (Figure 1B), whereas the positive
genotoxic control, EMS (20μg/ml) gave a mutation frequency of
240 mutant clones per 106 cells.
In order to ensure the reproducibility of the experiments, 8 of
the 12 ratswere randomly selected (four shamand fourRYGB) and
the analysis repeated using additional sampling time points (pre-
op, 2, 4, 6, and 8weeks post-op). The RSG values of L5178Ymouse
lymphoma cells exposed to RYGB fecal water extracts for 24 h was
markedly lower than sham extracts (Figure 2), indicating that
RYGB fecal water was toxic to the cells compared with sham fecal
water, which is consistent with the results derived from the initial
observation using six rats at two post-operative time points. How-
ever, cell survival following shamoperationwasmore variable than
RYGB surgery (Figure 2). Neither the sham nor the RYGB group
pre-surgery fecal water extracts were cytotoxic. Thus, the cyto-
toxicity observed in our experiments directly resulted from RYGB
surgery. As expected, the positive cytotoxic control (etoposide)
induced cytotoxicity.
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A B
FIGURE 1 | Determination of the relative suspension growth as a
measure of cytotoxicity (A) and genotoxicity (B) of fecal water extracts
following treatment of L5178Y mouse lymphoblastoid cells for 24h. Data
represent mean±SEM of six independent samples. The negative control (NC)
replaced fecal material with water and EMS (20μg/ml) was used as a positive
genotoxin. ***p<0.001 vs. negative control by one way ANOVA test.
FIGURE 2 | Determination of the relative suspension growth (RSG) of
L5178Y mouse lymphoblastoid cells after 24h exposure to individual
fecal water extracts from four sham and four RYGB-operated rats at
pre-surgery, 2, 4, 6, and 8weeks post surgery.The negative control (NC)
replaced fecal material with water and EMS (20μg/ml) was used as a
positive genotoxin whilst etoposide (73.5 ng/ml) was used as a positive
cytotoxin. **p<0.01, ***p<0.001 vs. negative control by one way
ANOVA test.
MICROBIAL-METABOLIC-CYTOTOXICITY AXIS
To understand the relationship between the microbiota, metabo-
lites, and the extent of cytotoxicity observed in our cell culture sys-
tem, a statistical integration method was applied to correlate mul-
tiple datasets. O-PLS regression analysis was performed to identify
correlation between (i) the NMR fecal and urine extracts and RSG
values (Figures 3A,B) and (ii) the RSG values and selected bac-
terial families (Figure 4). The fecal aromatic amino acid tyrosine
was found to be positively correlated with cell survival whereas
fecal tyramine, uracil, glycine, gamma-aminobutyric acid (GABA)
andputrescine,andurinary indoxyl sulfate,phenylacetylglycine,4-
cresyl glucuronide, 4-cresyl sulfate, 4-hydroxylphenylacetate, for-
mate, and 5-aminovalerate appeared to be associated with lower
RSG levels.
To enhance the correlation strength and minimize the inter-
animal variation, the fecal water extracts from four rats sampled
at ﬁve time points as described above were subjected to NMR
spectroscopic analysis in the second experiment. A direct O-PLS
correlation analysis was applied based on fecal water NMRproﬁles
and RSG from cytotoxicity proﬁles (Figure 3C). The metabolic-
cell growth correlationwas consistent with aforementioned results
from the initial dataset but with a stronger (Q2Y= 0.55) and
clearer model, where tyramine, methylamine, pyruvate, GABA,
and putrescine were directly associated with cell death whereas
butyrate, known as amajor nutrient of colonic cells, was positively
correlated with cell survival.
To investigate the association between the observed changes
in the microbiome at a gross level and cytotoxicity levels, 22
bacterial familial levels were correlated with RSG of the cells fol-
lowing fecal water treatment. Enterobacteriaceae, Pasteurellaceae,
Lachnospiraceae, and Ruminococcaceae levels were found to be sig-
niﬁcantly (p< 0.01) correlated with RSG of the cells following
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FIGURE 3 | O-PLS regression analyses of fecal water (A) and urine
extracts (B) against relative suspension growth values obtained from a
24-h treatment of L5178Y cells with sham or RYGB-operated rat fecal
extracts (week 2 and week 8) or O-PLS regression analyses of fecal
water extracts against relative suspension growth obtained from 24h
treatment of L5178Y cells with two sham or two RYGB fecal water
extracts [pre-surgery and 2, 4, 6, and 8weeks post surgery (C)]. Peaks
pointing upward in the loadings plots represent the metabolites are positively
correlated to the cell growth and visa versa. Red peaks reach a signiﬁcance
level of p<0.005. Keys: GABA, gamma-aminobutyric acid; IS, indoxyl sulfate;
PAG, phenylacetylglycine; p-cresyl sulf, p-cresyl sulfate; p-cresyl glu, p-cresyl
glucuronide.
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FIGURE 4 | Scatter plots of normalized bacterial levels (Enterobacteriaceae, Pasteurellaceae, Lachnospiraceae, and Ruminococcaceae) and
relative suspension growth of L5178Y mouse lymphoblastoid cells exposed to fecal water extracts of six sham and six RYGB rats at weeks 2
and 8 post intervention. Orange: RYGB-2weeks post op; Red: RYGB-8weeks post op; Green: Sham-2weeks post op; Blue: Sham-8weeks post op.
treatment and the scatter plots of normalized bacterial levels and
RSG values are illustrated in Figure 4. Levels of Enterobacteriaceae
and Pasteurellaceae appear to be inversely correlated with cell sur-
vival,whereas levels of Lachnospiraceae andRuminococcaceae were
positively related to the RSG.
DISCUSSION
Contrary to our initial expectations, based on recent epidemiolog-
ical ﬁndings that bariatric surgery is associated with lower cancer
risk, this exploratory study has clearly shown that RYGB surgery in
aWistar ratmodel increases the cytotoxicity of fecalmatter as indi-
cated bymarked reduction in (RSG) as a measure of cell death in a
well-established rodent reporter cell line. Furthermore, this cyto-
toxicity proﬁle of fecal water post-RYGB operation was strongly
correlated with the fecal and urinary metabolic phenotypes with
fecal concentrations of putrescine, uracil, tyramine, GABA, and
methylamine being inversely correlated with cell survival, whereas
butyrate was positively associated with cell survival. In addition to
the correlation between fecal amines and cell death, several urinary
metabolites also demonstrated an inverse correlation with cell
survival, including indoxyl sulfate, phenylacetylglycine, 4-cresyl
glucuronide, 4-cresyl sulfate, 4-hydroxylphenylacetate, formate,
and 5-aminovalerate.
UPREGULATION OF AMINE METABOLISM
Putrescine is a polyamine found ubiquitously in eukaryotic cells
and is vital for cell growth (Tabor and Tabor, 1984; Pegg, 1988).
However, high intracellular polyamine accumulation, either from
an imbalance in the cellular homeostatic mechanisms or exoge-
nous supply, could have a deleterious effect on cell survival (Mar-
ton et al., 1991; Davis et al., 1992; Casero and Pegg, 1993; Buckton
and Machiste, 1997). For example, treating polymorphonuclear
cells with 1mM putrescine for 30min resulted in the induction of
apoptosis, possibly through a caspase speciﬁc pathway (Mariggio
et al., 2004). Further to this, administrationof an exogenous supply
of putrescine has been shown to result in intracellular accumula-
tion with ensuing apoptosis in a hepatoma cell line (Tome et al.,
1997) and in amousemyeloma cell line (Tobias andKahana,1995).
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Our study revealed a post-operative increase in fecal putrescine
levels that correlated with the degree of fecal cytotoxicity based
on a cell based assay, and may contribute to the induction of cell
death following RYGB.
One likely mechanism for the rise in fecal putrescine after
surgery may reﬂect the microbial catabolism of incompletely
digested proteins reaching the colon as a result of surgical bypass
of the foregut (Welters et al., 1999; Li et al., 2011). Alterna-
tively the increase in post-operative fecal putrescine levels may
occur as a result of its anti-inﬂammatory properties. Intracellu-
lar polyamines such as putrescine are known to possess powerful
anti-inﬂammatory properties (Lovaas and Carlin, 1991) and have
been demonstrated as a response to gut and liver inﬂamma-
tion (Bird et al., 1983). Using a carrageenan-induced edema rat
model, putrescine was found to possess a tenfold higher anti-
inﬂammatory activity than spermidine (Bird et al., 1983). The
increase in polyamines is likely to negativelymodulate the immune
response through its action on leukocyte activity (Ferrante et al.,
1986; Quemener et al., 1994). We and others (Evrard et al., 1993)
have noted that bariatric surgery induces signiﬁcant macroscopic
trophic changes in the intestinal mucosa of animal models (more
than two-fold increase in mucosal mass) that may reﬂect an
increased post-operative gut inﬂammatory state. Consequently
a post-operative increase in fecal putrescine may occur as an
anti-inﬂammatory response to surgically induced inﬂammation.
Gamma-amino butyric acid, an inhibitory neurotransmitter in
the mammalian central nervous system, is also increased in fecal
samples post-RYGB and was found to inversely correlate with cell
survival in our cytotoxicity assays. The increased GABA concen-
tration in fecal water could be due to the high putrescine level as
GABA can be derived from the microbial processing of putrescine
(Kurihara et al., 2010). Increased expression of fecal GABA is
consistent with the well-deﬁned increase in glucagon-like peptide
(GLP-1) after RYGB surgery (Ashraﬁan and le Roux, 2009). GABA
stimulates GLP-1 release from intestinal cells (Gameiro et al.,
2005), and raised GLP-1 concentrations in turn promote GABA
formation by pancreatic β cells, with autocrine and paracrine
effects, including immunomodulatory actions on inﬁltrating T
cells to suppress autoimmune damage (Urbain et al., 1990).
Although we have suggested the cytotoxicity observed in our
system following RYGB surgery may be a result of putrescine,
it may be likely to involve both multiple monoamines such as
methylamine, as well as polyamines. Horse serum used in the cell
culture medium this study contains high semicarbazide-sensitive
amine oxidase (SSAO) activity (Tipnis and He, 1998) which can
convert methylamine to formaldehyde, ammonia, and hydrogen
peroxide, all of which are cytotoxic (Lyles, 1996; Gubisne-Haberle
et al., 2004). SSAO mediated degradation of methylamine has
been shown to be cytotoxic to cultured endothelial cells (Yu
and Zuo, 1993). Increased tyramine and decreased tyrosine levels
were observed in RYGB-operated rats. Tyramine is a monoamine,
derived from the microbial enzymatic decarboxylation of tyro-
sine by various lactic acid bacteria (Komprda et al., 2008) and has
also been reported to be produced by Enterobacter spp. strains
from food studies on cheese and meat (Marino et al., 2000; Curiel
et al., 2011). This is consistent with the marked increase in Enter-
obacter observed following RYGB surgery. Although tyramine was
reported to be mutagenically inactive using the mouse lymphoma
assay (McGregor et al., 1988),mutagenesis was only observed after
the combined treatment of tyramine and nitrite in vitro (Fujie
et al., 1990).
URACIL METABOLISM
One of the strongest correlates with cytotoxicity following RYGB
surgery was fecal uracil levels. Possible rationales for this phenom-
enon relate to apoptosis and inﬂammation. There is an increased
incidence of apoptosis in inﬂamed colonic mucosa in cases of
inﬂammatory bowel disease (Afford and Randhawa, 2000) that is
associated with impaired mucosal healing (Iwamoto et al., 1996).
Uracil has been previously reported to possess anti-apoptotic
activity in a human colon epithelial cell line (Evans et al., 2005)
and may be produced as a consequence following RYGB surgery
in rats to compensate for the ensuing inﬂammation. An alterna-
tive explanation would be modulation of inﬂammation. Nitric
oxide (NO) can be produced from the surrounding tissue and
macrophages during inﬂammatory process, tomodulate the extent
of inﬂammation (Nussler andBilliar,1993) and can reactwith oxy-
gen to form the nitrosating agent nitrous anhydride which can, in
turn, react with nucleophiles, such as amines and thiols (Caulﬁeld
et al., 1998). This propensity to react with nucleophiles can lead
to nitrosation of primary amine groups in a DNA base leading
to direct DNA damage, for example, the deamination of cytosine
to uracil (Barnes and Lindahl, 2004). Uracil in genomic DNA can
be repaired through excision by Uracil-DNA glycosylase leaving
an abasic site creating a substrate for base excision repair (Hagen
et al., 2008). It is plausible that uracil may be released during cell
lysis caused by the inﬂammation following RYGB surgery.
PROTECTIVE FUNCTION OF BUTYRATE
The short chain fatty acid butyrate is produced by bacterial fer-
mentation of dietary ﬁber and has important physiological roles
inmaintaining health and integrity of colonicmucosa (Clarke and
Mulcahey, 1976). It also regulates colonic epithelial cell prolifera-
tion and differentiation. Increased carbohydrate fermentation can
divert ammonia, which is toxic to colonic epithelial cells (Lin and
Visek, 1991), into de novo bacterial protein synthesis. Butyrate
enema treatment has been shown to reduce inﬂammatory colitis
in rats (Butzner et al., 1996). Indeed, the anti-inﬂammatory role of
butyrate through the inhibition of NF-κB activation in cultured
human cells from patient biopsies has also been demonstrated
(Segain et al., 2000).
CONCLUSION
The current study has for the ﬁrst time integrated measures of
cytotoxicity with metabolic and microbial phenotypes following
bariatric surgery, which may shed some light on the reduced inci-
dence of colonic cancer following weight loss surgery. Various
fecal metabolites were found to correlate with cytotoxicity mea-
sures. In essence, cytotoxicity was dramatically increased following
RYGB in a rat surgical model and this increase was associated with
alterations in both the metabolic and the microbial phenotypes
with particularly strong correlations between RSG and the Enter-
obacteriaceae and Pasteurellaceae. The metabolites suggested to
be responsible for the cytotoxic effect, based on statistical asso-
ciations, can be predominantly associated with an inﬂammatory
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response following surgery, which was persistent over the 8-week
study. Although it would have been interesting to follow the cyto-
toxic proﬁle for a longer period, ethical considerations did not
allow this.
In contrast to reports from large-scale human epidemiologi-
cal cohorts suggesting a reduced cancer risk following bariatric
surgery (Ashraﬁan et al., 2011a), we have demonstrated increased
fecal cytotoxicity in thisWistar ratmodel following RYGB surgery;
which can be associated with increased colonic cancer risk (de Kok
and van Maanen, 2000). Two possible explanations for the con-
ﬂicting RYGB effects between humans and rats include: (i) the rat
model is not translational to humans with regard to RYGB surgery,
or more controversially that the RYGB surgery increases the cyto-
toxicity of feces, however human colonocytes, are subject to a high
degree of oxidative stress and possess enzymes capable of detoxi-
fying H2S and other toxins (Ramasamy et al., 2006), are resistant
to this toxicity. The latter explanation however does not clarify
the nature of the decreased cancer risk after bariatric surgery.
As these operations are being increasingly performed worldwide
within a framework of increased global obesity andmetabolic dys-
function (Ashraﬁan et al., 2011b), an increased understanding of
the mechanisms and consequences of bariatric surgery are essen-
tial, speciﬁcally in terms of cancer risk. The future of this ﬁeld
will require an integrated metabolic, metagenomic, and cytotoxic
proﬁling approach in bariatric patients that have undergonemeta-
bolic surgery within robust clinical trials. This can strengthen our
understanding of the cancer modifying mechanisms of bariatric
surgery to improve the cancer related outcomes associated with
metabolic dysfunction and obesity.
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